Sex hormone levels and risk of breast cancer with estrogen plus progestin (Q37209551)

19 August 2017

Sex hormone levels and risk of breast cancer with estrogen plus progestin (English)

1 reference

19 August 2017

7

Eric Vittinghoff

0 references

Jane A. Cauley

object named as

Jane A Cauley

10

0 references

JoAnn E. Manson

4

object named as

Joann E Manson

1 reference

19 August 2017

9

Andrea Z Lacroix

1 reference

19 August 2017

3

Rowan T Chlebowski

1 reference

19 August 2017

5

Garnet Anderson

1 reference

19 August 2017

11

Rebecca Jackson

1 reference

19 August 2017

16

Steven R Cummings

1 reference

19 August 2017

13

Dorothy S Lane

1 reference

19 August 2017

1

Ghada N Farhat

1 reference

19 August 2017

2

Neeta Parimi

1 reference

19 August 2017

6

Alison J Huang

1 reference

19 August 2017

Jennifer S Lee

8

1 reference

19 August 2017

Deborah Grady

12

1 reference

19 August 2017

Lawrence Phillips

14

1 reference

19 August 2017

Michael S Simon

15

1 reference

19 August 2017

language of work or name

English

0 references

publication date

16 September 2013

1 reference

Journal of the National Cancer Institute

19 August 2017

1 reference

19 August 2017

105

1 reference

19 August 2017

19

1 reference

19 August 2017

1496-1503

1 reference

Changing concepts: Menopausal hormone therapy and breast cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Baseline serum estradiol and fracture reduction during treatment with hormone therapy: the Women's Health Initiative randomized trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

The Women's Health Initiative recruitment methods and results

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(o-carboxymethyl)oximino-[125l]-iodo-histamine as radioligand

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Aromatase and breast cancer susceptibility

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Serum estradiol level and risk of breast cancer during treatment with raloxifene

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

A critical evaluation of simple methods for the estimation of free testosterone in serum

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breast Cancer: a Nested Case-Control Study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787910

Implementation of the women's health initiative study design

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24041978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sex Hormones in Postmenopausal Women Receiving Low-Dose Hormone Therapy: The Effect of BMI

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24041978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJT243

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

24041978

1 reference